Effect of Tredaptive on Serum Lipoproteins, Lipoproteins Metabolism, Oxidative Stress and HDL Antioxidant Function.

Trial Profile

Effect of Tredaptive on Serum Lipoproteins, Lipoproteins Metabolism, Oxidative Stress and HDL Antioxidant Function.

Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Nov 2014

At a glance

  • Drugs Niacin/laropiprant (Primary)
  • Indications Hypercholesterolaemia
  • Focus Therapeutic Use
  • Most Recent Events

    • 11 Oct 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 02 Feb 2012 Status changed from recruiting to active, no longer recruiting United Kingdom Clinical Research Network record.
    • 24 Jan 2012 United Kingdom Clinical Research Network record reports accrural to date changed from 92% to 100%.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top